Filed: 5/14/2024ACC: 0001974915-24-000005
📋 What this filing means
VESTAL POINT CAPITAL, LP filed this quarterly 13F‑HR report disclosing 58 equity positions with a total reported market value of $1.21B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
58
Positions
$1.21B
Total AUM (reported)
52.35M
Total Shares
Allocation by class
COM$557.05M46.1%
COM NEW$209.23M17.3%
SPONSORED ADR$176.98M14.6%
SHS USD$132.46M11.0%
CL A$58.83M4.9%
SHS$37.18M3.1%
COM PAR $.01$20.35M1.7%
Portfolio Concentration
Top 3$381.12M31.5%
4–10$362.77M30.0%
11–25$281.74M23.3%
Rest$183.58M15.2%
Top 3 weight
31.5%
Top 10 weight
61.5%
Voting Authority Distribution
Total shares with voting rights: 52.35M
Sole
Full voting authority
52.35M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole58
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings58
Rows:
Cytokinetics Inc
SOLEShares2.15M
TypeSH
Market value$150.74M
12.47%
Sole
2.15M
Shared
0.00
None
0.00
Jazz Pharmaceuticals PLC
SOLEShares1.10M
TypeSH
Market value$132.46M
10.95%
Sole
1.10M
Shared
0.00
None
0.00
Neurocrine Biosciences Inc
SOLEShares710K
TypeSH
Market value$97.92M
8.10%
Sole
710K
Shared
0.00
None
0.00
Ascendis Pharma A/S
SOLEShares525K
TypeSH
Market value$79.36M
6.56%
Sole
525K
Shared
0.00
None
0.00
Globus Medical Inc
SOLEShares1M
TypeSH
Market value$53.64M
4.44%
Sole
1M
Shared
0.00
None
0.00
Soleno Therapeutics Inc
SOLEShares1.25M
TypeSH
Market value$53.50M
4.42%
Sole
1.25M
Shared
0.00
None
0.00
Alnylam Pharmaceuticals Inc
SOLEShares350K
TypeSH
Market value$52.31M
4.33%
Sole
350K
Shared
0.00
None
0.00
BeiGene Ltd
SOLEShares325K
TypeSH
Market value$50.83M
4.20%
Sole
325K
Shared
0.00
None
0.00
Inari Medical Inc
SOLEShares800K
TypeSH
Market value$38.38M
3.17%
Sole
800K
Shared
0.00
None
0.00
Applied Therapeutics Inc
SOLEShares5.11M
TypeSH
Market value$34.75M
2.87%
Sole
5.11M
Shared
0.00
None
0.00
Liquidia Corp
SOLEShares2M
TypeSH
Market value$29.50M
2.44%
Sole
2M
Shared
0.00
None
0.00
ALX Oncology Holdings Inc
SOLEShares2.61M
TypeSH
Market value$29.10M
2.41%
Sole
2.61M
Shared
0.00
None
0.00
AstraZeneca PLC
SOLEShares400K
TypeSH
Market value$27.10M
2.24%
Sole
400K
Shared
0.00
None
0.00
uniQure NV
SOLEShares4.72M
TypeSH
Market value$24.57M
2.03%
Sole
4.72M
Shared
0.00
None
0.00
Insmed Inc
SOLEShares750K
TypeSH
Market value$20.35M
1.68%
Sole
750K
Shared
0.00
None
0.00
Argenx SE
SOLEShares50K
TypeSH
Market value$19.69M
1.63%
Sole
50K
Shared
0.00
None
0.00
Xenon Pharmaceuticals Inc
SOLEShares400K
TypeSH
Market value$17.22M
1.42%
Sole
400K
Shared
0.00
None
0.00
TG Therapeutics Inc
SOLEShares1.05M
TypeSH
Market value$15.97M
1.32%
Sole
1.05M
Shared
0.00
None
0.00
Astria Therapeutics Inc
SOLEShares1.10M
TypeSH
Market value$15.48M
1.28%
Sole
1.10M
Shared
0.00
None
0.00
BioMarin Pharmaceutical Inc
SOLEShares175K
TypeSH
Market value$15.28M
1.26%
Sole
175K
Shared
0.00
None
0.00
Alpine Immune Sciences Inc
SOLEShares350K
TypeSH
Market value$13.87M
1.15%
Sole
350K
Shared
0.00
None
0.00
Solid Biosciences Inc
SOLEShares1.03M
TypeSH
Market value$13.79M
1.14%
Sole
1.03M
Shared
0.00
None
0.00
Dianthus Therapeutics Inc
SOLEShares455K
TypeSH
Market value$13.65M
1.13%
Sole
455K
Shared
0.00
None
0.00
Apellis Pharmaceuticals Inc
SOLEShares225K
TypeSH
Market value$13.23M
1.09%
Sole
225K
Shared
0.00
None
0.00
Sarepta Therapeutics Inc
SOLEShares100K
TypeSH
Market value$12.95M
1.07%
Sole
100K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Cytokinetics IncSOLE | COM NEW | 2.15M | SH | $150.74M 12.47% | 2.15M | 0.00 | 0.00 |
Jazz Pharmaceuticals PLCSOLE | SHS USD | 1.10M | SH | $132.46M 10.95% | 1.10M | 0.00 | 0.00 |
Neurocrine Biosciences IncSOLE | COM | 710K | SH | $97.92M 8.10% | 710K | 0.00 | 0.00 |
Ascendis Pharma A/SSOLE | SPONSORED ADR | 525K | SH | $79.36M 6.56% | 525K | 0.00 | 0.00 |
Globus Medical IncSOLE | CL A | 1M | SH | $53.64M 4.44% | 1M | 0.00 | 0.00 |
Soleno Therapeutics IncSOLE | COM | 1.25M | SH | $53.50M 4.42% | 1.25M | 0.00 | 0.00 |
Alnylam Pharmaceuticals IncSOLE | COM | 350K | SH | $52.31M 4.33% | 350K | 0.00 | 0.00 |
BeiGene LtdSOLE | SPONSORED ADR | 325K | SH | $50.83M 4.20% | 325K | 0.00 | 0.00 |
Inari Medical IncSOLE | COM | 800K | SH | $38.38M 3.17% | 800K | 0.00 | 0.00 |
Applied Therapeutics IncSOLE | COM | 5.11M | SH | $34.75M 2.87% | 5.11M | 0.00 | 0.00 |
Liquidia CorpSOLE | COM NEW | 2M | SH | $29.50M 2.44% | 2M | 0.00 | 0.00 |
ALX Oncology Holdings IncSOLE | COM | 2.61M | SH | $29.10M 2.41% | 2.61M | 0.00 | 0.00 |
AstraZeneca PLCSOLE | SPONSORED ADR | 400K | SH | $27.10M 2.24% | 400K | 0.00 | 0.00 |
uniQure NVSOLE | SHS | 4.72M | SH | $24.57M 2.03% | 4.72M | 0.00 | 0.00 |
Insmed IncSOLE | COM PAR $.01 | 750K | SH | $20.35M 1.68% | 750K | 0.00 | 0.00 |
Argenx SESOLE | SPONSORED ADR | 50K | SH | $19.69M 1.63% | 50K | 0.00 | 0.00 |
Xenon Pharmaceuticals IncSOLE | COM | 400K | SH | $17.22M 1.42% | 400K | 0.00 | 0.00 |
TG Therapeutics IncSOLE | COM | 1.05M | SH | $15.97M 1.32% | 1.05M | 0.00 | 0.00 |
Astria Therapeutics IncSOLE | COM | 1.10M | SH | $15.48M 1.28% | 1.10M | 0.00 | 0.00 |
BioMarin Pharmaceutical IncSOLE | COM | 175K | SH | $15.28M 1.26% | 175K | 0.00 | 0.00 |
Alpine Immune Sciences IncSOLE | COM | 350K | SH | $13.87M 1.15% | 350K | 0.00 | 0.00 |
Solid Biosciences IncSOLE | COM NEW | 1.03M | SH | $13.79M 1.14% | 1.03M | 0.00 | 0.00 |
Dianthus Therapeutics IncSOLE | COM | 455K | SH | $13.65M 1.13% | 455K | 0.00 | 0.00 |
Apellis Pharmaceuticals IncSOLE | COM | 225K | SH | $13.23M 1.09% | 225K | 0.00 | 0.00 |
Sarepta Therapeutics IncSOLE | COM | 100K | SH | $12.95M 1.07% | 100K | 0.00 | 0.00 |
Page 1 of 3